| |
| |
| |
| Introduction to Clinical Exercise Physiology | |
| |
| |
| |
| Introduction | |
| |
| |
| The Past, Present, and Future of Clinical Exercise Physiology | |
| |
| |
| Professional Organizations and Certifications | |
| |
| |
| Employment Opportunities and Professional Viability | |
| |
| |
| Conclusion | |
| |
| |
| |
| Behavioral Approaches to Physical Activity Promotion | |
| |
| |
| Health Benefits of Physical Activity | |
| |
| |
| Fitness Benefits of Physical Activity | |
| |
| |
| Participation in Regular Physical Activity | |
| |
| |
| Risk Assessment | |
| |
| |
| Theories and Models of Physical Activity Promotion | |
| |
| |
| Conclusion | |
| |
| |
| |
| Legal Considerations | |
| |
| |
| The American Legal System | |
| |
| |
| Important State Statutory Definitions | |
| |
| |
| Exercise Testing and Prescription As Medical Procedures | |
| |
| |
| The Clinical Exercise Physiologist's Duties and Responsibilities | |
| |
| |
| Conclusion | |
| |
| |
| |
| General Evaluation and Examination Skills | |
| |
| |
| Clinical Evaluation | |
| |
| |
| Physical Examination | |
| |
| |
| Conclusion | |
| |
| |
| |
| Pharmacotherapy | |
| |
| |
| Metabolic Agents | |
| |
| |
| Hormones and Steroids | |
| |
| |
| Cardiovascular Agents | |
| |
| |
| Drugs of Abuse | |
| |
| |
| Conclusion | |
| |
| |
| |
| Graded Exercise Testing | |
| |
| |
| Personnel | |
| |
| |
| Indications | |
| |
| |
| Contraindications | |
| |
| |
| Graded Exercise Testing Protocols | |
| |
| |
| Graded Exercise Testing Procedures | |
| |
| |
| Exercise ECG Analysis | |
| |
| |
| Emergency Procedures | |
| |
| |
| Conclusion | |
| |
| |
| |
| General Exercise Prescription Development | |
| |
| |
| Exercise Training Sequence | |
| |
| |
| Goal Setting | |
| |
| |
| Principles of Exercise Prescription | |
| |
| |
| Cardiorespiratory Endurance | |
| |
| |
| Skeletal Muscle Strength and Endurance | |
| |
| |
| Flexibility | |
| |
| |
| Conclusion | |
| |
| |
| |
| Endocrinology and Metabolic Disorders | |
| |
| |
| |
| Diabetes | |
| |
| |
| Scope | |
| |
| |
| Physiology and Pathophysiology | |
| |
| |
| Clinical Considerations | |
| |
| |
| Exercise Prescription | |
| |
| |
| Conclusion | |
| |
| |
| |
| Obesity | |
| |
| |
| Scope | |
| |
| |
| Physiology and Pathophysiology | |
| |
| |
| Clinical Considerations | |
| |
| |
| Exercise Prescription | |
| |
| |
| Conclusion | |
| |
| |
| |
| Hyperlipidemia and Dislipidemia | |
| |
| |
| Scope | |
| |
| |
| Physiology and Pathophysiology | |
| |
| |
| Clinical Considerations | |
| |
| |
| Exercise Prescription | |
| |
| |
| Conclusion | |
| |
| |
| |
| End Stage Renal Disease | |
| |
| |
| Scope | |
| |
| |
| Physiology and Pathophysiology | |
| |
| |
| Clinical Considerations | |
| |
| |
| Exercise Prescription | |
| |
| |
| Conclusion | |
| |
| |
| |
| Cardiovascular Diseases | |
| |
| |
| |
| Myocardial Infarction | |
| |
| |
| Scope | |
| |
| |
| Physiology and Pathophysiology | |
| |
| |
| Clinical Considerations | |
| |
| |
| Exercise Prescription | |
| |
| |
| Conclusion | |
| |
| |
| |
| Revascularization of the Heart | |
| |
| |
| Coronary Artery Bypass Surgery | |
| |
| |
| Percutaneous Transluminal Coronary Angioplasty | |
| |
| |
| Stent Therapy | |
| |
| |
| Clinical considerations | |
| |
| |
| Graded Exercise Testing | |
| |
| |
| Exercise Prescription | |
| |
| |
| Conclusion | |
| |
| |
| |
| Valvular Heart Disease | |
| |
| |
| Scope | |
| |
| |
| Physiology and Pathophysiology | |
| |
| |
| Clinical Considerations | |
| |
| |
| Exercise Prescription | |
| |
| |
| Conclusion | |
| |
| |
| |
| Chronic Heart Failure | |
| |
| |
| Scope | |
| |
| |
| Physiology and Pathophysiology | |
| |
| |
| Clinical Considerations | |
| |
| |
| Exercise Prescription | |
| |
| |
| Conclusion | |
| |
| |
| |
| Hypertension | |
| |
| |
| Scope | |
| |
| |
| Physiology and Pathophysiology | |
| |
| |
| Clinical Considerations | |
| |
| |
| Exercise Prescription | |
| |
| |
| Conclusion | |
| |
| |
| |
| Peripheral Vascular Disease | |
| |
| |
| Scope | |
| |
| |
| Physiology and Pathophysiology | |
| |
| |
| Clinical Considerations | |
| |
| |
| Exercise Prescription | |
| |
| |
| Conclusion | |
| |
| |
| |
| Pacemakers and Internal Cardiac Defibrillators | |
| |
| |
| Pacing System | |
| |
| |
| Physiology and Pathophysiology | |
| |
| |
| Graded Exercise Testing | |
| |
| |
| Exercise Prescription | |
| |
| |
| Automatic Internal Cardioverter Defibrillators | |
| |
| |
| Conclusion | |
| |
| |
| |
| Diseases of the Respiratory System | |
| |
| |
| |
| Chronic Obstructive Pulmonary Disease | |
| |
| |
| Scope | |
| |
| |
| Physiology and Pathophysiology | |
| |
| |
| Clinical Considerations | |
| |
| |
| Exercise Prescription | |
| |
| |
| Conclusion | |
| |
| |
| |
| Asthma | |
| |
| |
| Scope | |
| |
| |
| Physiology and Pathophysiology | |
| |
| |
| Clinical Considerations | |
| |
| |
| Exercise Prescription | |
| |
| |
| Conclusion | |
| |
| |
| |
| Cystic Fibrosis | |
| |
| |
| Scope | |
| |
| |
| Physiology and Pathophysiology | |
| |
| |
| Clinical Considerations | |
| |
| |
| Exercise Prescription | |
| |
| |
| Conclusion | |
| |
| |
| |
| Oncology and the Immune System | |
| |
| |
| |
| Cancer | |
| |
| |
| Scope | |
| |
| |
| Physiology and Pathophysiology | |
| |
| |
| Clinical Considerations | |
| |
| |
| Exercise Prescription | |
| |
| |
| Conclusion | |
| |
| |
| |
| Human Immunodeficiency Virus | |
| |
| |
| Scope | |
| |
| |
| Physiology and Pathophysiology | |
| |
| |
| Clinical Considerations | |
| |
| |
| Signs and Symptoms | |
| |
| |
| Exercise Prescription | |
| |
| |
| Conclusion | |
| |
| |
| Glossary | |
| |
| |
| References | |
| |
| |
| |
| Disorders of Bone and the Joints | |
| |
| |
| |
| Arthritis | |
| |
| |
| Scope | |
| |
| |
| Physiology and Pathophysiology | |
| |
| |
| Clinical Considerations | |
| |
| |
| Exercise Prescription | |
| |
| |
| Conclusion | |
| |
| |
| |
| Osteoporosis | |
| |
| |
| Scope | |
| |
| |
| Physiology and Pathophysiology | |
| |
| |
| Clinical Considerations | |
| |
| |
| Exercise Prescription | |
| |
| |
| Conclusion | |
| |
| |
| |
| Selected Neuromuscular Disorders | |
| |
| |
| |
| Nonspecific Low Back Pain | |
| |
| |
| Scope | |
| |
| |
| Physiology and Pathophysiology | |
| |
| |
| Clinical Considerations | |
| |
| |
| Exercise Prescription | |
| |
| |
| Conclusion | |
| |
| |
| |
| Spinal Cord Injury | |
| |
| |
| Scope | |
| |
| |
| Physiology and Pathophysiology | |
| |
| |
| Clinical Considerations | |
| |
| |
| Exercise Prescription | |
| |
| |
| Conclusion | |
| |
| |
| |
| Multiple Sclerosis | |
| |
| |
| Scope | |
| |
| |
| Physiology and Pathophysiology | |
| |
| |
| Clinical Considerations | |
| |
| |
| Exercise Prescription | |
| |
| |
| Conclusion | |
| |
| |
| |
| Special Populations | |
| |
| |
| |
| Children | |
| |
| |
| Scope | |
| |
| |
| Physiology and Pathophysiology | |
| |
| |
| Laboratory Evaluations and Exercise Testing | |
| |
| |
| Exercise Prescription | |
| |
| |
| Conclusion | |
| |
| |
| |
| Elderly | |
| |
| |
| Conclusion | |
| |
| |
| Scope | |
| |
| |
| Physiology and Pathophysiology | |
| |
| |
| Clinical Considerations | |
| |
| |
| Exercise Prescription | |
| |
| |
| Conclusion | |
| |
| |
| |
| Females | |
| |
| |
| Amenorrhea | |
| |
| |
| Osteoporosis | |
| |
| |
| Clinical Considerations | |
| |
| |
| Exercise Prescription | |
| |
| |
| Conclusion | |